| Diabetes and cancer: Pathophysiological fundamentals of a ‘dangerous affair’ A Cignarelli, VA Genchi, I Caruso, A Natalicchio, S Perrini, L Laviola, ... Diabetes research and clinical practice 143, 378-388, 2018 | 81 | 2018 |
| Heterogeneity and similarities in GLP-1 receptor agonist cardiovascular outcomes trials I Caruso, A Cignarelli, F Giorgino Trends in Endocrinology & Metabolism 30 (9), 578-589, 2019 | 55 | 2019 |
| Cardiovascular and renal effectiveness of GLP-1 receptor agonists vs. other glucose-lowering drugs in type 2 diabetes: a systematic review and meta-analysis of real-world studies I Caruso, A Cignarelli, GP Sorice, A Natalicchio, S Perrini, L Laviola, ... Metabolites 12 (2), 183, 2022 | 42 | 2022 |
| SGLT-2 inhibitors as cardio-renal protective agents I Caruso, F Giorgino Metabolism 127, 154937, 2022 | 30 | 2022 |
| Titratable fixed-ratio combination of insulin glargine plus lixisenatide: a simplified approach to glycemic control in type 2 diabetes mellitus F Giorgino, I Caruso, R Napoli diabetes research and clinical practice 170, 108478, 2020 | 28 | 2020 |
| Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS‐CoV‐2 outbreak in type 1 diabetes I Caruso, S Di Molfetta, F Guarini, F Giordano, A Cignarelli, A Natalicchio, ... Diabetes/metabolism research and reviews 37 (6), e3404, 2021 | 26 | 2021 |
| Differential indication for SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with established atherosclerotic heart disease or at risk for congestive heart failure F Giorgino, I Caruso, J Moellmann, M Lehrke Metabolism 104, 154045, 2020 | 23 | 2020 |
| Role of glucose-lowering medications in erectile dysfunction A Cignarelli, VA Genchi, R D’Oria, F Giordano, I Caruso, S Perrini, ... Journal of clinical medicine 10 (11), 2501, 2021 | 20 | 2021 |
| Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study M Baviera, A Foresta, P Colacioppo, G Macaluso, MC Roncaglioni, ... Cardiovascular Diabetology 21 (1), 162, 2022 | 19 | 2022 |
| The diabetic lung: An easy target for SARS‐CoV‐2? I Caruso, F Giorgino Diabetes/Metabolism Research and Reviews 36 (8), 2020 | 16 | 2020 |
| New insights into the treatment of non-healing diabetic foot ulcers. G Vicenti, D Bizzoca, I Caruso, VS Nappi, G Giancaspro, M Carrozzo, ... Journal of Biological Regulators and Homeostatic Agents 32 (6 Suppl. 1), 15-21, 2018 | 16 | 2018 |
| Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta‐analysis S Di Molfetta, I Caruso, A Cignarelli, A Natalicchio, S Perrini, L Laviola, ... Diabetes, Obesity and Metabolism 25 (5), 1301-1310, 2023 | 14 | 2023 |
| Thyroid and shoulder diseases: the bases of a linked channel. G Vicenti, L Moretti, S De Giorgi, I Caruso, M La Malfa, M Carrozzo, ... Journal of biological regulators and homeostatic agents 30 (3), 867-870, 2016 | 13 | 2016 |
| Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis I Caruso, L Di Gioia, S Di Molfetta, A Cignarelli, SC Palmer, P Natale, ... EClinicalMedicine 64, 2023 | 11 | 2023 |
| Glucagon in type 2 diabetes: Friend or foe? I Caruso, N Marrano, G Biondi, VA Genchi, R D'Oria, GP Sorice, S Perrini, ... Diabetes/Metabolism Research and Reviews 39 (3), e3609, 2023 | 11 | 2023 |
| Diabetes in the time of covid-19: A twitter-based sentiment analysis A Cignarelli, A Sansone, I Caruso, S Perrini, A Natalicchio, L Laviola, ... Journal of diabetes science and technology 14 (6), 1131-1132, 2020 | 10 | 2020 |
| GLP-1 receptor agonists for cardiovascular protection: a matter of time I Caruso, A Cignarelli, L Laviola, F Giorgino Diabetes Care 45 (2), e30-e31, 2022 | 8 | 2022 |
| Commentary: Glucose control: Not just a bystander in GLP-1RA-mediated cardiovascular protection I Caruso, A Cignarelli, A Natalicchio, S Perrini, L Laviola, F Giorgino Metabolism-Clinical and Experimental 109, 2020 | 8 | 2020 |
| Mini review: Effect of GLP-1 receptor agonists and SGLT-2 inhibitors on the growth Hormone/IGF axis A Cignarelli, VA Genchi, G Le Grazie, I Caruso, N Marrano, G Biondi, ... Frontiers in Endocrinology 13, 846903, 2022 | 7 | 2022 |
| Cardiovascular and renal effectiveness of GLP-1 receptor agonists vs other glucose-lowering drugs in type 2 diabetes: a systematic review and meta-analysis of real-world … I Caruso, A Cignarelli, GP Sorice, A Natalicchio, S Perrini, L Laviola, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 7 | 2022 |
